Navigation Links
Data on VIVUS' Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
Date:10/1/2009

MOUNTAIN VIEW, Calif., Oct. 1 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(TM), an investigational new drug, will be presented this Friday, October 2, 2009 at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria. This presentation follows last month's unprecedented phase 3 data for Qnexa, which demonstrated statistically significant weight loss with all three doses of Qnexa, as well as significant improvements in cardiovascular and metabolic risk factors including blood pressure, lipid levels, and blood sugar.

"This has been an exciting year for VIVUS and Qnexa. Last month, we announced pivotal phase 3 data from two year-long obesity studies, EQUIP and CONQUER, demonstrating a favorable safety profile for Qnexa as well as unprecedented weight loss, impressive glycemic control, and significant improvements in cardiovascular and metabolic risk factors," stated Leland Wilson, president and chief executive officer of VIVUS. "The enthusiasm among physicians, patients and pharmaceutical companies for a new option capable of helping patients achieve such clinically meaningful results is significant."

Wilson added, "We are also delighted that Dr. Timothy Garvey, a leading expert in metabolic disorders recognized for his research in the metabolic, molecular, and genetic pathogenesis of insulin resistance, type 2 diabetes, and obesity will present data from our previously reported phase 2 diabetes study at the EASD annual meeting. This will be the first opportunity to share this data with the European medical and pharmaceutical community."

The data being presented is from the previously announced year-long phase 2 trial (DM-230) evaluating Qnexa in patients with type 2 diabetes. The study demonstrated that Qnexa significantly redu
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
2. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
3. Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii
4. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
5. Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting
6. NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting
7. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
8. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
9. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
10. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
11. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 7, 2011 EntreMed, Inc. (Nasdaq: ENMD ... treatment of cancer, today announced that Selected Value Therapeutics ... an exclusive license to develop and commercialize EntreMed,s Phase ... of its territories.  EntreMed retains development and commercialization rights ...
... June 7, 2011 Topaz Pharmaceuticals Inc., a privately ... Food and Drug Administration (FDA) accepted for filing the ... topical cream as a treatment for head lice infestations ... represents the transition of the Company from the development ...
Cached Medicine Technology:Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China 2Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China 3Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China 4Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA 2Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA 3
(Date:7/10/2014)... the clinical indicators most strongly associated with concussion is ... evidence-based guidelines for concussion diagnosis, prognosis, and treatment, according ... , official journal of the Congress ... Lippincott Williams & Wilkins , a part of ... on analysis of the best available research data, a ...
(Date:7/10/2014)... just as tempting as full-fat equivalents could be ... into how proteins can replace fats without affecting ... the Engineering and Physical Sciences Research Council (EPSRC), ... of Edinburgh has produced modified proteins that easily ... the behaviour of fats during food manufacture. The ...
(Date:7/9/2014)... that sudden, acute episodes of low back pain are ... air pressure, wind direction and precipitation. Findings published in ... the American College of Rheumatology (ACR), indicate that the ... wind speed or wind gusts, but was not clinically ... (WHO) nearly everyone experiences low back pain at some ...
(Date:7/9/2014)... in almost all types of cancer sends the protein ... fuel a tumour,s uncontrolled growth, new research suggests. , ... a molecular trigger responsible for ratcheting up activity of ... makes the building blocks cancer cells need to keep ... called SREBP, controls the flow of messages to the ...
(Date:7/9/2014)... found that fecal transplantation is effective and safe for ... is the result of a study led by Colleen ... Gastrointestinal Medicine at The Women,s Medicine Collaborative. The study ... of print in the American Journal of Gastroenterology ... diff , has increased to epidemic proportions over the ...
Breaking Medicine News(10 mins):Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:Great tasting low-fat cheeses and cakes could soon be on the menu 2Health News:Low back pain? Don't blame the weather 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2
... confirms that impotence is a risk factor for heart ... suffering from both cardiovascular disease and erectile dysfunction are ... and death, a new study finds. , Moreover, treatments ... so the German researchers concluded that erectile dysfunction is ...
... ... between the corporate and academic worlds in the medical device industry. , ... (PRWEB) March 15, 2010 -- The First Annual ... Hosted by the Biomedical Engineering Society @ San Jose State University, this event will take ...
... ... at Children,s Memorial Hospital may be able to identify infants at high risk ... 48 hours after birth. The medical device making this possible is called the Pea ... fast, non-invasive mechanism to measure newborn body fat. , ...
... Reno , Salt Lake City , and Denver in May are set to help employers improve hearing conservation efforts and prevent noise-induced hearing loss among their workers. , ... , ... ... ...
... The Greater San Antonio Chamber of Commerce and ... at a luncheon on March 31st who have made ... part of the 2010 Women,s Opportunity Week (WOW), Ford Motor Company ... McClendon ( Texas State Representative, District 120 ), ...
... NEW YORK , March 15 Expectant mothers ... pregnancy experience thanks to the new Prenatal Yoga for Partners ... organic baby and toddler food company. One of the only products ... and founder Shazi Visram and her husband, Joe ...
Cached Medicine News:Health News:Erectile Dysfunction Plus Heart Disease Raises Death Risk 2Health News:Erectile Dysfunction Plus Heart Disease Raises Death Risk 3Health News:First Annual Bay Area Biomedical Device Conference to be Held at San Jose State University 2Health News:First Annual Bay Area Biomedical Device Conference to be Held at San Jose State University 3Health News:Study to Identify Infants at High Risk for Developing Obesity 2Health News:Study to Identify Infants at High Risk for Developing Obesity 3Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 2Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 3Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 4Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 5Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 6Health News:Free Seminars to Help Employers Prevent Noise-Induced Hearing Loss Among Workers Set for Phoenix, Reno, Salt Lake City, Denver in May 7Health News:San Antonio Chamber Honors Women Business, Community Leaders 2Health News:San Antonio Chamber Honors Women Business, Community Leaders 3Health News:San Antonio Chamber Honors Women Business, Community Leaders 4Health News:HAPPYBABY Unveils Partners Prenatal Instructional Yoga DVD 2Health News:HAPPYBABY Unveils Partners Prenatal Instructional Yoga DVD 3Health News:HAPPYBABY Unveils Partners Prenatal Instructional Yoga DVD 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: